Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Research site

CDG Studienambulanz Dr. Hartard

Germany Helene-Mayer-Ring 14, 80809 Munich, Germany

  • Obesity · Overweight
  • Adult patients

About Specializations

CDG Studienambulanz Dr. Hartard in Munich, Germany specialises in clinical trials of conditions such as Obesity, Overweight, and other specialisations. This site conducts important research.

Main research areas of the site

Nutritional and Metabolic Diseases – Chronic Weight Management

The CDG Studienambulanz Dr. Hartard focuses on nutritional and metabolic diseases, specifically addressing chronic weight management in adult patients.

  • Evaluation of weight reduction efficacy with an investigational therapy
  • Assessment of long‑term safety profile
  • Monitoring tolerability over extended treatment periods

Ongoing research seeks to demonstrate the efficacy of a novel weight‑management agent, while also characterizing its long‑term safety and tolerability for individuals living with obesity or overweight.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Helene-Mayer-Ring 1480809 MunichGermany
Open in maps ↗
Recruiting now
no trials
Conditions studied
2

More sites in MunichGermany

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Phase 2b Study of VXB-221 and VXB-213 Protein Vaccine for Prevention of Respiratory Syncytial Virus and Human Metapneumovirus Infections in Adults ≥60 Years

Not yet recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Sponsor:Sanofi Pasteur Inc.

Obesity+1

Not yet recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Obesity

Not yet recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Obesity+1

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.